China ‘leads world in coronavirus research’, followed by United States
China is leading the world in coronavirus research, with the highest number of active clinical studies under way, according to a new ranking by a financial information provider based in Britain.
The Coronavirus Research Index, launched by Finbold.com, has identified nearly 300 ongoing research projects in 39 countries and regions, all of which have confirmed cases of the novel coronavirus.
China has 60 ongoing studies, followed by 49 in the United States and 26 in France, according to an analysis of all active Covid-19 clinical research recorded by the US-based ClinicalTrials.gov database.
These countries “are putting the biggest efforts in understanding and dismantling coronavirus, thus helping to find an effective way to treat the disease”, Finbold.com said.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
South Korea Initiates Anti-Dumping Probe on Chinese PVC Suspension Resin, Involving Tianjin Bohua and Wanhua Chemical
-
China Keeps Registering Pesticides
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
INEOS Warns Chinese Chemical “Dumping” Is Hitting Europe’s Industry
-
Covestro Builds New 660,000-ton MDI Plant in China: Global Supply Gap Meets Chinese Overcapacity Head-On
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
EU Finalizes Anti-Dumping Duties on BDO from China, with Rates up to 113.7%
-
EU mulls expanding tariff scope on Chinese chemicals, sector-wide measures in the pipeline
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
Recommend Reading
-
CPHI China 2026 Concludes Successfully, ECHEMI Serves Global Pharmaceutical Clients
-
Review of the 93rd API China: In Chongqing, Witnessing the Global Pulse of the Pharmaceutical Industry
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices
-
From API China to the Global Pharmaceutical Chain: ECHEMI Is Reshaping the "New Speed" of Pharmaceutical Trade
-
When Global Buyers No Longer Visit Trade Shows but “Select Suppliers with a Click”
-
Cost Support Limited, Maleic Anhydride Prices in China Drop Significantly
-
Covestro Minority Shareholder Squeeze-Out Price Set at €59.46 per Share
-
High Crude Prices Are Passing Through the Coatings Chain as More Than 20 Companies Launch Price Increases
-
Premium Global Chemical Sourcing Requests (13-15Apr, 2026)
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition